Job title: VP, Allogeneic Research
Jo is one of the founding scientists at Adaptimmune and has been part of the evolution of the company as it has grown from 5 people to 400. She has 18 years’ research experience in immunology and the biotech industry, specialising in TCRs and adoptive T–cell therapy for oncology. Currently she leads a team striving to develop an allogeneic platform creating the off-the-shelf T-cell therapies from pluripotent stem cells. Previously she has led several research teams including next gen modifications to T-cell biology to improve T-cell therapeutic efficacy and generating T-cell clones as a source of TCR for affinity enhancement.
Prior to joining Adaptimmune, Jo led a research team at Avidex working on small molecule inhibitors and soluble proteins for treating rheumatoid arthritis and other autoimmune diseases by blocking T–cell activity. Jo holds a PhD and MA (Natural Sciences) from the University of Cambridge, UK.